High Outlier
DEA Schedule CV
Strength
165 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888005030
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA215249On Market Since
3/22/2022
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.